Effectiveness of interferon-beta and temozolomide combination therapy against temozolomide-refractory recurrent anaplastic astrocytoma

BACKGROUND: Malignant gliomas recur even after extensive surgery and chemo-radiotherapy. Although a relatively novel chemotherapeutic agent, temozolomide (TMZ), has demonstrated promising activity against recurrent glioma, the effects last only a few months and drug resistance develops thereafter in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Fujimaki, Takamitsu, Ishii, Hisato, Matsuno, Akira, Arai, Hajime, Nakagomi, Tadayoshi
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2007
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1976115/
https://ncbi.nlm.nih.gov/pubmed/17683572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-5-89
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars